Semliki Forest virus (SFV) non-structural protein 1 (nsP1) is a major component of the virus replicase complex. It has previously been studied in cells infected with virus or using transient or stable expression systems. To extend these studies, tetracycline-inducible stable cell lines expressing SFV nsP1 or its palmitoylation-negative mutant (nsP1 6D ) were constructed. The levels of protein expression and the subcellular localization of nsP1 in induced cells were similar to those in virus-infected cells. The nsP1 expressed by stable, inducible cell lines or by SFV-infected HEK293 T-REx cells was a stable protein with a half-life of approximately 5 h. In contrast to SFV infection, induction of nsP1 expression had no detectable effect on cellular transcription, translation or viability. Induction of expression of nsP1 or nsP1 6D interfered with multiplication of SFV, typically resulting in a 5-10-fold reduction in virus yields. This reduction was not due to a decrease in the number of infected cells, indicating that nsP1 expression does not block virus entry or initiation of replication. Expression of nsP1 interfered with virus genomic RNA synthesis and delayed accumulation of viral subgenomic RNA translation products. Expression of nsP1 with a mutation in the palmitoylation site reduced synthesis of genomic and subgenomic RNAs and their products of translation, and this effect did not resolve with time. These results are in agreement with data published previously, suggesting a role for nsP1 in genomic RNA synthesis.
INTRODUCTION
Semliki Forest virus (SFV) belongs to the genus Alphavirus (family Togaviridae). Along with Sindbis virus (SV), the prototype member of the genus, SFV is one of the most studied alphaviruses. The genome of SFV is a positivestrand RNA of approximately 11.5 kb with a 59 cap and a 39 terminal poly(A) tract (Kääriäinen et al., 1987) . The 59 two-thirds of the genome encodes the non-structural (ns) polyprotein P1234. In infected cells, P1234 is autocatalytically cleaved into four individual non-structural proteins designated nsP1, nsP2, nsP3 and nsP4 (Kääriäinen et al., 1987) . The SFV-encoded protease, nsP2, is responsible for proteolytic processing of P1234 (Merits et al., 2001; Lulla et al., 2006a) . The first cleavage takes place at the nsP3/4 cleavage site and releases mature nsP4, which together with the remaining P123 polyprotein forms the early minusstrand RNA replicase. In contrast, the late replicase complex consists of fully processed non-structural proteins and synthesizes positive-sense genomic and subgenomic (sg) RNA molecules (Lemm et al., 1994; Shirako & Strauss, 1994; Vasiljeva et al., 2003; Kim et al., 2004) . nsP1 participates directly in initiation and elongation of the minus-strand RNA synthesis of alphaviruses (Sawicki et al., 1981; Hahn et al., 1989; Wang et al., 1991) . During minus-strand RNA synthesis, nsP1 interacts with nsP4 (Shirako et al., 2000; Fata et al., 2002) . The properties of nsP1 of SFV and SV have been studied previously using infected cells, transient and stable expression systems, and purified recombinant proteins. The N-terminal region of nsP1 is a methyltransferase and guanylyltransferase involved in capping the viral positive-strand RNAs (Mi et al., 1989; Mi & Stollar, 1991; Laakkonen et al., 1994; Ahola & Kääriäinen, 1995; Wang et al., 1996; Ahola et al., 1997) . nsP1 is also associated with cellular membranes (Peränen et al., 1995) and serves as the sole membrane anchor for the virus replicase complex (Salonen et al., 2003) . Two different events are involved in binding of nsP1 to cellular membranes. Firstly, the amphipathic peptide segment, located in the central part of nsP1, binds to cellular membranes (Ahola et al., 1999; Lampio et al., 2000) . This binding is required for activation of the enzymic activities of nsP1 and for infectivity of the viral genome . Secondly, post-translational palmitoylation at cysteine residues 418-420 is responsible for strong membrane association of the protein (Laakkonen et al., 1996) . Palmitoylation as such is not required for the enzymic activities of nsP1 or for infectivity of the viral genome (Ahola et al., 2000; Ž usinaite et al., 2007) . However, the deletion or substitution of cysteines 418-420 in nsP1 of SFV results in a severe defect in virus replication and causes accumulation of compensatory mutations. This effect may result from the incorrect subcellular localization of mutant nsP1 and/or from its inability to interact with nsP4 (Ž usinaite et al., 2007) . Li et al. (1997) demonstrated that stable transfectants of Hela cells, expressing nsP1 from low-methionine (LM)-adapted SV, SV(LM21), were able to support replication of standard SV in cells maintained in LM medium. The expression of full-length nsP1 had only a minor affect on replication of SV(LM21), but truncated forms of nsP1 acted as dominant-negative mutants.
Within the first few hours, alphavirus infection results in exclusion of superinfection by homologous virus (Adams & Brown, 1985) and, in the case of vertebrate cells, in shutdown of host-cell gene expression and induction of apoptotic death. It has been shown or proposed that free nsP2 is required for these effects (Karpf et al., 1997; Garmashova et al., 2006 Garmashova et al., , 2007 Sawicki et al., 2006) ; however, it has not been demonstrated whether expression of other non-structural proteins causes similar effects. nsP1 expression in infected or transfected cells results in prominent changes, such as induction of filopodia-like structures and rearrangements of actin filaments (Laakkonen et al., 1998) . These nsP1-induced effects make it another candidate for superinfection exclusion and/or virus-induced cytotoxic effects.
We studied the properties of nsP1 and its effect on host cells and on SFV infection by combining two powerful approaches, tetracycline-inducible stable cell lines and recombinant SFV genomes carrying marker genes in the replicase or the structural open reading frame (ORF). nsP1 expressed alone in the absence of the other virus replicase proteins was a stable protein with a half-life of about 5 h; stability was not affected by virus infection. Expression of nsP1 induced prominent changes in cell membranes and cell morphology, but had no significant effect on cell viability, virus entry or establishment of virus replication. However, nsP1 expression suppressed genomic RNA synthesis leading to reduced virus yield. The palmitoylation-negative form of nsP1 acted as a dominant-negative mutant and suppressed both genomic and sgRNA synthesis. 6D were designated T-REx-nsP1 and T-REx-nsP1 6D , respectively, and were grown at 37 uC with 5 % CO 2 in Iscove's modified Dulbecco's medium (IMDM; Gibco) supplemented with 10 % fetal calf serum, blasticidin (5 mg ml 21 ) and zeocin (30 mg ml 21 ).
METHODS
SFV, recombinant viruses and cell infection. BHK-21 cells, used for multiplication and plaque titration of SFV stocks, were grown as described previously (Ž usinaite et al., 2007) . SFV4(3H)-Rluc and SFV4-StRluc containing insertion of the Renilla luciferase (Rluc) reporter were constructed as described by Tamberg et al. (2007) and Thomas et al. (2003) , respectively. SFV4, SFV4(3H)-Rluc and SFV4-StRluc were generated from corresponding infectious cDNAs, as described previously (Liljeström & Garoff, 1991) , grown and plaque titrated in BHK-21 cells, and used for infection of HEK293 T-REx cells or constructed cell lines.
Analysis of transcription and translation in stable cell lines. TREx-nsP1 cells were grown on 60 mm dishes to 75 % confluency and induced with tetracycline for 24 h; uninduced cultures were used as controls. RNA transcripts were labelled with 10 mCi (370 kBq) [5-3 H]uridine (Amersham Biosciences) in 1 ml serum-free IMDM for 1 h. Cells were then collected, washed with PBS and lysed in 200 ml 1 % SDS, followed by heating at 65 uC for 5 min. To label cellular proteins, the induced cells were first incubated for 30 min in methionine-and cysteine-free medium, followed by pulse labelling with 50 mCi (1.85 MBq) [
35 S]methionine and [
35
S]cysteine for 30 min. Pulse-chase experiments were carried out as described by Lulla et al. (2006b) . The lysates of 5-3 H-or 35 S-labelled cells were precipitated with 1 ml 10 % trichloroacetic acid and the incorporated radioactivity was measured using a 1414 Liquid Scintillation Counter (Wallac). S]cysteine as described above. For the transcription analysis, total RNA from equal amounts of infected and mock-infected cells was isolated using Trizol reagent (Invitrogen) and dissolved in 30 ml DEPC-treated water. Total RNA (10 ml) was subjected to denaturing formaldehyde agarose gel electrophoresis (Sambrook & Russell, 2001 ). The RNA bands corresponding to cellular pre-mRNAs and mRNAs (the gel area above the SFV4 42S RNA band) were excised from the gel, placed into 3 ml scintillation liquid and the radioactivity quantified by liquid scintillation counting. The translation analysis was carried out as described by Tamm et al. (2008) . Inhibition of cellular translation was assessed by measuring the radioactivity incorporated into the protein band corresponding to actin, as described previously (Gorchakov et al., 2004) . Immunoprecipitation of [
35 S]methionine-and [ 35 S]cysteinelabelled samples was carried out as described previously (Tamm et al., 2008) .
Immunofluorescence and confocal microscopy. Cells at 75 % confluency were induced with tetracycline or infected with SFV4 at an m.o.i. of 20 for 6 h. Uninduced or mock-infected cells were used as a control. Cells were then fixed, permeabilized and treated with specific anti-nsP1 antibodies (Laakkonen et al., 1994) and rhodamineconjugated concanavalin A (ConA; Sigma) for plasma membrane staining as described previously and analysed with a Bio-Rad MRC-1024 confocal microscope.
Immunoblotting. Lysates prepared from equal amounts of induced or uninduced cells were separated by SDS-PAGE (~10 5 cells per cell line). Proteins were transferred to a membrane and detected by antibodies against nsP1 using enhanced chemiluminescence.
WST-1 assay for cell viability. T-REx-nsP1 and T-REx-nsP1 6D cells were seeded in 96-well plates (9610 4 cells per well) and allowed to grow for 18 h. Recombinant protein expression was induced for 24 h; control cells remained uninduced. For comparison, the parental HEK293 T-REx cell line was infected with SFV4 at an m.o.i. of 20 or was mock infected, and cells were incubated for 24 h. Subsequently, 20 ml WST-1 (Roche) was added to each well and the plate was incubated for a further 1 h under the cell culture growing conditions. A 450 was read in a microplate reader. This experiment was repeated at least three times for each cell line.
Analysis of Rluc activity in infected cells. HEK293 T-REx, T-RExnsP1 and T-REx-nsP1 6D cells grown on 35 mm dishes were induced with tetracycline or mock induced, and infected with SFV4(3H)-Rluc or SFV4-StRluc at an m.o.i. of 0.6. EnduRen Live Cell Substrate (Promega) was added to the medium immediately after infection and the Rluc activity was measured at selected time points using a Glomax 20/20 luminometer (Promega).
Northern blot analysis. HEK293 T-REx, T-REx-nsP1 and T-RExnsP1 6D cells grown on 35 mm dishes were induced with tetracycline or mock induced, and infected with SFV4(H3)-Rluc at an m.o.i. of 0.6. At 12 h post-infection (p.i.), total RNA from infected cells was purified using Trizol reagent (Invitrogen). Each RNA sample (10 mg) was used for Northern blotting as described previously (Tamm et al., 2008) using an RNA probe complementary to the positive-strand of SFV genomic (nt 10951-11445) and sgRNA.
Statistical methods and software. The data from radioactive gels were quantified using Image Quant (Molecular Dynamics) software. Student's t-test was used for calculation of statistical significance.
RESULTS

Evaluation of the half-life of nsP1 and its subcellular localization
Stably transfected cell lines inducible for the expression of wild-type (wt) nsP1 or its palmitoylation-negative form (nsP1 6D ) were constructed and analysed. Tetracyclineinduced expression of nsP1 and nsP1 6D was confirmed by immunoblotting (Fig. 1a) . The level of wt nsP1 expression reached a plateau at 12 h post-induction (data not shown) and was similar to that of SFV4-infected HEK293 T-REx cells at 6 h p.i. The expression of nsP1 6D was somewhat lower than that of wt nsP1. Thus, in contrast to previously reported Hela cell lines expressing SV nsP1 (Li et al., 1997) , induced T-REx-nsP1 cells did not overexpress SFV nsP1. In our stably transfected inducible T-REx cells, the half-life of nsP1 and nsP1 6D , as measured by metabolic labelling, was 5 h (Fig. 1b) , indicating that nsP1 was highly stable and that this was not changed by mutation of the palmitoylation site. For comparison, the half-life of nsP1 in SFV4-infected HEK293 T-REx cells was determined and found to be approximately 4 h (Fig. 1b) .
In induced T-REx-nsP1 cells, nsP1 localized mostly to the plasma membrane, resulting in the extensive formation of filopodia-like structures. In contrast to SFV4-infected HEK293 T-REx cells, induced nsP1 did not localize to intracellular vesicles (Fig. 2) . nsP1 6D also localized predominantly to the plasma membrane, but few filopodia-like structures were induced (Fig. 2) . Thus, the half-life and, to some extent, the subcellular localization of nsP1 in induced cell lines were similar to those observed in infected cells.
Effects of nsP1 expression
The effect of nsP1 expression on cellular transcription and translation was analysed by metabolic labelling. As 6D from pulse-chased cells was immunoprecipitated, separated by SDS-PAGE and analysed by phosphorimaging. Each experiment was performed at least twice, with no significant difference between the datasets (Student's t-test). The amount of incorporated label immediately after the pulse (0 h) (inducible cell lines) or after a 1 h chase (for SFV-infected cells; as in infected cells, the amount of nsP1 initially increases as a result of its release from precursors) was taken as 100 %. Quantification was made for label incorporated into immunoprecipitated nsP1 from induced cell lines (X) and from infected cells (m) and for label incorporated into immunoprecipitated nsP1
6D from induced cell lines (&).
Properties of SFV nsP1
expected, SFV4 infection significantly reduced synthesis of cellular pre-mRNA and mRNA. The reduction was approximately threefold (Fig. 3a) . In contrast, there was no statistically significant reduction in cellular transcription following induction of nsP1 expression (Fig. 3a) . Similarly, SFV4 infection led to an almost complete shutdown of cellular translation by 24 h p.i. (Fig. 3b) , whilst induction of nsP1 expression caused no significant effect.
As nsP1 localizes on the plasma membrane, it may act as an inducer of cell death, for example by activating cell-surface deaths receptors. A WST-1 cell viability assay revealed that, whilst SFV4 infection considerably reduced viability of HEK293 T-REx cells at 24 h p.i., induction of nsP1 or nsP1 6D expression had no effect on cell viability (Fig. 3c ). Taken together, these results showed that SFV nsP1 expression causes significant morphological changes in cells but on its own has no effect on transcription, translation or viability.
nsP1 expression by HEK293 cells does not affect virus entry but interferes with virus replication
The growth curves of SFV4 in HEK293 T-REx cells, treated or mock treated with tetracycline 12 h prior to infection or at the same time as infection, were essentially identical (Fig. 4a) . The same result was obtained for infection of these cells by SFV4 viruses carrying a Renilla luciferase marker gene in the non-structural ORF [SFV4(3H)-Rluc] or in the structural ORF (SFV4-StRluc) (data not shown). As the addition of tetracycline did not have any effect on the replication of SFV in HEK293 T-REx cells and 12 h treatment achieved expression of recombinant protein at levels typically found in SFV-infected cells, these conditions were used in subsequent experiments.
Recombinant nsP1 and nsP1
6D localized to the plasma membrane of induced cells. To investigate whether this had any effect on the entry of SFV, the T-REx-nsP1, T-RExnsP1 6D and HEK293 T-REx cells were infected with viruslike particles (VLPs) containing packaged SFV1-d1EGFP replicons, capable of infection and d1EGFP expression, but unable to produce infectious progeny (Ž usinaite et al., 2007) . The percentage of d1EGFP-positive cells at 12 h p.i. for HEK293 T-REx and uninduced T-REx-nsP1 cells was found to be approximately five times lower than for BHK-21 cells. The susceptibility of uninduced T-REx-nsP1 6D cells was reduced even further, reaching only 25 % that of HEK293 T-REx cells. These relative susceptibilities were reproduced when the full-length EGFP-expressing virus SFV4(3H)-EGFP (Tamberg et al., 2007) was used for infection of these cell lines. Therefore, in all subsequent experiments the number of virions or VLPs used for infection of each cell line was selected according to the individual susceptibilities of the cell lines, e.g. four times more infectious material was used for infection of T-RExnsP1 6D cells to achieve the same m.o.i. as for HEK293 T-REx or T-REx-nsP1 cells. Induction of nsP1 or nsP1 6D expression did not affect infection efficiency in any cell line (Fig. 4b) . Thus, expression of nsP1 or nsP1 6D did not affect the ability of SFV VLPs to enter into cells and establish replication.
To determine whether expression of nsP1 or nsP1 6D interferes with SFV infection, induced or mock-induced HEK293 T-REx, T-REx-nsP1 and T-REx-nsP1 6D cell lines were infected with SFV4 and the virus titres at 8 and 12 h p.i. were compared. As expected, addition of tetracycline 12 h prior to infection did not have a significant effect on the multiplication of SFV4 in HEK293 T-REx cells (Fig. 4c) . In contrast, induction of the expression of nsP1 or nsP1 6D significantly decreased SFV4 titres (Fig. 4c) . At 8 h p.i., the decrease in titre was greater in induced T-REx-nsP1 cells than in induced T-REx-nsP1 6D cells. At 12 h p.i., the situation was reversed: the titre from induced T-REx-nsP1 cells was only decreased 2.5-fold compared with almost a 5-fold decrease observed in induced T-REx-nsP1 6D cells (Fig. 4c) . Thus, the expression of wt nsP1 of SFV or its palmitoylation-negative mutant inhibited extracellular accumulation of virus.
Expression of nsP1 or nsP1 6D interferes with different steps in the SFV infection process
Given that nsP1 did not affect virus entry (Fig. 4b) , the reduced extracellular virus titres observed following nsP1 or nsP1 6D expression could reflect defects in production of viral transcripts, virus structural proteins, or assembly and release of virions. To determine whether expression of nsP1 or nsP1 6D had any effect on virus protein synthesis, the reporter viruses SFV4(3H)-Rluc and SFV4-StRluc were used to monitor the translation of genomic and sgRNAs. Translation of genomic RNA is proportional to its copy number only at early stages of infection; late in infection, translation of genomic RNAs is inhibited but RNA synthesis remains active. Expression of RLuc in cells infected with SFV4(3H)-Rluc was therefore measured only during the first 6 h of infection. Rluc activity produced by SFV4-StRluc should be proportional to the amount of expressed viral structural proteins throughout the course of infection and this was monitored up to 12 h p.i. Treatment of HEK293 T-REx cells with tetracycline prior to infection with marker viruses resulted in increased translation of the replicase ORF (Fig. 5a ) but had no effect on translation of the structural protein ORF (Fig. 5b) . In contrast, tetracycline induction of the T-REx-nsP1 cell line resulted in up to a 4-fold reduction in replicase ORF-derived Rluc activity (Fig. 5c ). Marker expression, mediated by the sgRNA, was strongly suppressed only in the early stages of infection; by 12 h p.i., no difference between induced and uninduced cells was detectable (Fig. 5d) . Induction of the T-REx-nsP1 6D cell line resulted in less than 2-fold reduction in replicase ORF-derived Rluc activity (Fig.  5e ), but caused strong and persistent inhibition of structural protein ORF-derived RLuc activity (Fig. 5f) , indicating that the mechanism of action of the mutant protein differed from that of wt nsP1.
Rluc activity produced by SFV4(3H)-Rluc or SFV4-StRluc depends on copy number of viral RNAs, availability of these for translation, rates of translation, extent and timing of shut-off of host cell and replicase translation, and stability of the marker protein. To determine whether nsP1 or nsP1 6D expression affected levels of viral RNA, total RNA was extracted from induced and mock-induced HEK293 T-REx, T-REx-nsP1 and T-REx-nsP1
6D cells 12 h after infection with SFV4(3H)-Rluc and analysed by Northern blotting. The amounts of viral RNAs in mockinduced HEK293 T-REx and T-REx-nsP1 cells were similar to each other, whilst the viral RNA level in uninduced TREx-nsP1 6D cells was slightly lower (Fig. 6) . Treatment of HEK293 T-REx cells with tetracycline had no effect on viral RNA levels. Induction of nsP1 expression decreased the amount of genomic RNA and, to some extent, the amount of sgRNA (Fig. 6) . Thus, nsP1 expression specifically inhibited the synthesis of genomic RNA. In contrast, induction of nsP1 6D expression resulted in a strong reduction of both genomic and sgRNAs (Fig. 6) . The results obtained by Northern blot analysis and those obtained by analysis of marker protein expression from recombinant viruses correlated and indicate that expression of nsP1 and nsP1 6D exerts different effects on SFV replication.
DISCUSSION
Inducible expression of recombinant protein from stable cell lines has several advantages over systems based on transient expression. Firstly, induction with tetracycline causes no damage to the cells, reaches efficiencies close to 100 % and, on its own, does not affect SFV infection. Secondly, the level of recombinant gene expression is precisely controlled, as all cells in any selected cell clone have a fixed copy number of recombinant genes. Importantly, inducible systems allow expression of potentially toxic viral proteins, and inducible cell lines do not adapt to constant expression of the recombinant protein.
For these reasons, stable inducible cell lines represent excellent tools for analysis of the in vivo properties of individual virus proteins and for studies of the effects of these on cellular metabolism, viability and virus replication. That nsP1 is a stable protein with a half-life of over 4 h, both in SFV-infected and tetracycline-induced cells, suggests that it may act in replicase complexes to stabilize more unstable viral proteins such as nsP4. It was previously found that infection of stable Hela-(SV) nsP1 cells with SV resulted in a rapid decrease in methyltransferase activity, which was suggested to have resulted from virus-induced shutdown of cellular transcription and translation (Li et al., 1997) . This explanation assumed that 'cellular' nsP1 was rapidly degraded, although nsP1 stability was not measured. The high stability of SFV nsP1 suggests that the suppression of 'cellular' nsP1 activity by SV infection (Li et al., 1997) is unlikely to have originated from virusinduced shutdown of cellular protein expression; it is perhaps more likely to have resulted from virus-induced rearrangement of cellular membranes or virus-induced changes in the general metabolism of the cell.
Expression of nsP1 led to dramatic morphological changes in induced cells, especially in the plasma membrane. This finding is consistent with the observation that transient expression of nsP1 alone is capable of inducing the formation of filopodia-like structures (Laakkonen et al., 1998; Spuul et al., 2007) . The main difference in the localization of nsP1 in induced T-REx-nsP1 cells compared with infected cells was the lack of virus-induced intracellular replication complexes. Again, these data are coherent with the observation that, on its own, nsP1 is unable to induce formation of replication complex-like structures (Salonen et al., 2003) . Surprisingly, these morphological changes did not affect cell metabolism or viability. Indirectly, these findings support the hypothesis that nsP2 is the main factor responsible for the shutdown of cellular transcription/translation and induction of cell death in SFV-infected cells (Garmashova et al., 2007) . That expression of nsP1 or nsP1 6D did not reduce the number of cells in which SFV initiated replication also indicates that some other non-structural protein, again most probably nsP2, is the main mediator of superinfection exclusion (Karpf et al., 1997; Sawicki et al., 2006) .
Expression of nsP1 in HEK293 T-REx cells interfered with virus multiplication, resulting in reduced levels of virus genomic RNA, reduced levels of replicase proteins, delayed synthesis of structural proteins and reduced levels of infectious virus. SFV infection of induced T-REx-nsP1 cells closely resembled the Arg183 mutant of SV, which, due to a defect in negative-strand RNA synthesis, generates fewer replicase complexes but has enhanced sgRNA synthesis (Fata et al., 2002) . It can be speculated that nsP1 expression results in lower numbers of virus replicase complexes due to competition with P123 for binding of nsP4 (Shirako et al., 2000; Salonen et al., 2003) , incorrect incorporation into replicase complexes, inhibition of P123 or P1234 binding to membranes or interference with the translocation of replicase complexes. A reduction in replicase complex formation would result in reduced RNA replication, reduced levels of genomic RNA and reduced levels of replicase proteins, as was observed. The delayed accumulation of structural proteins could also be explained by a reduction in the number of virus replication complexes. Fewer replication complexes would result in a delay in the early synthesis of subgenomic transcripts and structural polyproteins. However, with time, perhaps these could, as was observed, accumulate to the levels seen in control cells (no nsP1 expression) due to exhaustion of metabolites or saturation of synthesis systems. An alternative explanation for the accumulation to 'normal' levels by 12 h of the subgenomic transcripts and structural polyproteins would be that nsP1 expression actively promotes increased production of sgRNA. Whatever the explanation, in nsP1-expressing cells, sufficient structural proteins were expressed and genomic RNA packaged to result in relatively high yields of virions.
In Hela cells, stable expression of mutated forms of nsP1 of SV(LM21) interferes with SV infection (Li et al., 1997) . Similarly, the inhibition of SFV multiplication by nsP1 6D was also significant, but was different to nsP1. The extent of inhibition was far less than observed with the terminal deletion mutants of SV(LM21). The more prominent inhibitory effects of SV nsP1 expression observed by Li et al. (1997) may be the consequence of their much higher recombinant protein expression levels. The inhibitory effect of nsP1 6D was relatively mild at early stages of infection but increased over time. That the effects of expression of nsP1 and nsP1 6D on SFV infection were different suggests that the mechanism(s) through which these proteins affect SFV infection may be different. Indeed, several differences in biological properties of nsP1 and nsP1 6D have been revealed. nsP1 6D cannot be palmitoylated, is less tightly bound to cellular membranes and a significant fraction of it is localized in the cytoplasm of transfected cells (Ahola et al., 2000; Ž usinaite et al., 2007) . SFV nsP1 6D is also unable to interact with nsP4 (Ž usinaite et al., 2007) . It cannot therefore compete with P123 for binding of nsP4 and may therefore be less efficient than wt nsP1 at blocking early replicase complex formation, resulting in the observed lower suppression of genomic RNA synthesis and non-structural protein expression. However, location of nsP1 6D on membranes could still result in incorporation into replicase complexes or affect replicase membrane interactions and thereby reduce replicative efficiency. nsP1
6D could still compete with replicase complexes for substrates for cap synthesis, as has also been suggested for one of the truncated forms of nsP1 of SV(LM21) (Li et al., 1997) .
